Skip To Main Content
Gaëlle Jamar on Muck Rack

Gaëlle Jamar

As seen in: The European Society of Gene and Cell Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Gaëlle Jamar’s profile

Articles by Gaëlle Jamar

R2-I Recognised Researcher (Therapeutics and innovations in neuropediatrics) - Vall D'Hebron, Barcelona

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
Open in Who Shared Issue with article?

SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” San Raffaele Hospital in Milan on 9–10 November 2026

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
SR-TIGET–Danaher Symposium, “Unlocking Access: Cell & Gene Therapy at Scale ” is taking place at San Raffaele Hospital in Milan on 9–10 November 2026, marking the 30th anniversary of SR-TIGET. The meeting will bring together leading researchers, clinicians, industry experts and patient representatives to discuss advances in hematopoietic stem cell gene therapy and genome editing, alongside key challenges in safety, manufacturing and sustainable patient access.
Open in Who Shared Issue with article?

Priora is hiring – 5 scientific roles in immune-cell delivery for neurological disease, London, UK

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Priora is an early-stage company building a delivery route for therapies to the brain, using engineered immune cells to reach specific cell subsets non-invasively. The team of ~15 researchers is based in London and San Francisco. Open roles, all London and full-time: VP of Translational Research; Senior Scientist, In Vivo Neuroscience; Senior Computational Scientist; Research Scientist, In Vitro; and Scientist, Mouse Models. Full details and application links for each role are on the careers page.
Open in Who Shared Issue with article?

Postdoc – Advanced Viral Vector Technology & Bioprocess Development - Leuven, Belgium

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Our research group, the Laboratory Molecular Vectorlogy and Gene Therapy (LMVGT) is part of ADVANTAGE labs (Advanced Disease Modeling, Targeted Drug Discovery and Gene Therapy), Dept. Pharmaceutical and Pharmacological Sciences, group Biomedical Sciences at KU Leuven, Belgium. Our mission is to advance viral vector engineering, technology development, production, and application for rare disease modelling and gene therapy.
Open in Who Shared Issue with article?

Help shape the future of gene & cell therapy policy in Europe

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The European Society of Gene & Cell Therapy (ESGCT) is looking for a Public Affairs & Health Policy Lead to establish and drive its European policy and advocacy function.
Open in Who Shared Issue with article?

GCure – University of Coimbra is recruiting a Group Leader in Gene Therapy

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The University of Coimbra (Portugal) is recruiting a Group Leader / Principal Investigator to join GCure, an ERA Chair project funded by Horizon Europe (GA 101186929), focused on strengthening Europe’s capacity in advanced gene therapy development.
Open in Who Shared Issue with article?

GeneT – University of Coimbra recruits three Group Leaders in Gene Therapy

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The University of Coimbra (Portugal) is recruiting three Group Leaders to join GeneT – The Gene Therapy Center of Excellence Portugal, a Horizon Europe Teaming for Excellence initiative.
Open in Who Shared Issue with article?

Lund University hires Assistant Professors in Immuno-oncology and Immunotherapy

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Lund University, Sweden are recruiting three tenure-track Assistant Professors in Immuno-Oncology and Immunotherapy. We are looking for candidates ready to build an internationally competitive research programme at the interface of immune engineering, mechanistic discovery, and clinical translation. The positions are part of the Lund University Programme for Global Excellence. This is a tenure-track position with a clear path to promotion and a substantial start-up package.
Open in Who Shared Issue with article?

FDA approval of LAD gene therapy

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Last Thursday, the FDA approved the LAD gene therapy developed by Juan A. Bueren and Elena Almarza, in collaboration with the Adrian Thrasher team. This treatment was licensed to Rocket Pharma, who developed the clinical trial and presented it to the FDA.
Open in Who Shared Issue with article?

ForTra gGmbH and the SPARK-BIH team cordially invite you to their joint workshop on GCT in Frankfurt/Main

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The ForTra gGmbH (the nonprofit subsidiary of the Else Kröner-Fresenius Foundation for research transfer) and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies cordially invite you to their joint workshop on GCT in Frankfurt/Main. Join ForTra and the SPARK-BIH team of the National Strategy for Gene- and Cell-Based Therapies for an inspiring, forward-looking workshop on Gene and Cell therapy (GCT) – one of the most dynamic fields shaping the future of medicine.
Open in Who Shared Issue with article?

Around the World: Global Seminar Series Australasia - Thursday 26 February 2026

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
AGCTS is proud to host the next session in the Around the World seminar series as part of the Coalition of International Gene Therapy Societies; a global partnership uniting leading gene and cell therapy organisations to strengthen international collaboration, share expertise, and accelerate the development of genetic medicines worldwide.
Open in Who Shared Issue with article?

PhD position, Anglia Ruskin University ARU

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
Open in Who Shared Issue with article?

FDA approval of the Biologics License Application (BLA) for Waskyra, the first gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The ESGCT would like to congratulate Fondazione Telethon and HSR-TIGET on the milestone achievement of the FDA approval of WAS ex vivo gene therapy. Please see below their statement: We are honoured to share a moment of profound significance for us, for patients, families, and the scientific community. The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Waskyra, the first gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Open in Who Shared Issue with article?

Postdoctoral Fellow, Gene and Cell Therapy, Institute for Regenerative Medicine, Zurich

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Start of employment 01.01.2026, temporary We are seeking an experienced postdoctoral researcher for developing and preclinical testing of innovative cell and gene therapy. Our laboratory is established at the Institute for Regenerative Medicine (IREM, www.irem.uzh.ch), a leading research institute of the University of Zurich (UZH) at the life-science research campus in Schlieren (ZH).
Open in Who Shared Issue with article?

Group Leader Position at the Telethon Institute of Genetics and Medicine (TIGEM)

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
TIGEM, an internationally renowned research center dedicated to understanding genetic diseases and developing transformative therapies, is seeking applications for Group Leader positions.
Open in Who Shared Issue with article?

Postdoc in Gene Editing, Tübingen

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
Open in Who Shared Issue with article?

Around the World: Oncology, Hematology, and Cancer-Focused Cell and Gene Therapy in India

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Our terms and conditions for: User account Membership Copyright ©2023 European Society of Gene and Cell Therapy
Open in Who Shared Issue with article?

Group Leader position at SR-TIGET (Milan, Italy)

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
The San Raffaele Telethon Institute for Gene Therapy (SR-TIGET - www.sr-tiget.it) is seeking tenure-track GROUP LEADERS wishing to develop ambitious research programs within the broader mission of the Institute to perform cutting edge research on gene and cell therapy and translate its results into therapeutic advances with a main focus on genetic diseases.
Open in Who Shared Issue with article?

Joint Postdoctoral Program at TIGEM and SR-Tiget

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Fondazione Telethon launches a new training initiative for early-career scientists at its flagship Institutes Fondazione Telethon is a leading Italian charity dedicated to funding and conducting scientific research on rare genetic diseases. Since its founding, it has promoted innovative therapies and groundbreaking research through its renowned Institutes: TIGEM (Telethon Insitute of Genetics and Medicine) in Pozzuoli and SR-Tiget (San Raffaele Insitute of Gene Therapy) in Milan.
Open in Who Shared Issue with article?

Phd-holding position in Gene Therapy, University of Coimbra (Portugal)

|
By Gaëlle Jamar
| The European Society of Gene and Cell Therapy
Phd-holding position in Gene Therapy: Project Manager & Regulatory Affairs Officer for CAPACITY 2023 University of Coimbra (Portugal) opens a call for a PhD-holding position in Project Manager & Regulatory Affairs Officer of the project Capacity 2023 (https://www.uc.pt/en/capacity/), Consortium for Developing Regulatory Capacity for Clinical Trials using Gene Therapy products and Strengthening Pharmacovigilance in the Conduct of Clinical Trials in East Africa (reference: 101145599), funded by...
Open in Who Shared Issue with article?
Show More